Sriveda Boyalakuntla, Riten Kumar
Dec 14, 2025, 12:56
Mentored by Riten Kumar, Sriveda Boyalakuntla Presents Key Research on Infection-Associated Thrombosis at ASH25
Kishore Boyalakuntla, GM and CPO at Re:Build Cadonix, reposted Riten Kumar’s post on LinkedIn:
“Congrats Sriveda Boyalakuntla on the work related to infection associated thrombosis. It is special to be mentored by Riten Kumar and the team at Boston Children’s Hospital.”
Quoting Riten Kumar’s post:
“Last day at ASH25 – interesting subgroup analysis from the RENOVE trial, increased CRNM bleeding with apixaban and aspirin, but not NSAIDs and Sriveda BoyalaKuntla’s excellent presentation on infection associated thrombosis, finished off with trainees – past, present and future!”
Get the latest on Hemostasis Today.
-
Jun 26, 2026, 02:06Giovanni Merlino: Scientific Progress in Secondary Stroke Prevention at Udine Stroke Congress 2026
-
Jun 26, 2026, 01:48Michael Stark: Highlights from ISBT 2026 on RBC Transfusion and NEC in Neonates
-
Jun 25, 2026, 23:08Geert Verheyden: Belgium’s Vision for Better Stroke Care Across the Continuum
-
Jun 25, 2026, 21:04Else Charlotte Sandset: Pleasure to Welcome Polish Delegation to Oslo University Hospital Stroke Tour
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026